Evidence map›Paper›PMID 22327213›Full record

ReviewCellular & molecular immunology2012

Human allograft rejection in humanized mice: a historical perspective.

Michael A Brehm, Leonard D Shultz

Open access · bronzeAbstract readReview
In one paragraph

Review in Cellular & molecular immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Current methods in translational cancer research.Cancer metastasis reviews · 2021
    Review
  5. Article
  6. AdvancedFrontiers in immunology · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Humanized Mouse Models of Clinical Disease.Annual review of pathology · 2017
    Review
  12. Review
  13. Humanized Mouse Models for Transplant Immunology.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Review
  14. Application of Humanized Mice in Immunological Research.Methods in molecular biology (Clifton, N.J.) · 2016
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael A BrehmProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. michael.brehm@umassmed.edu
Leonard D Shultz
Jackson Laboratory · USUniversity of Massachusetts Chan Medical School · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 1999 to 2014
$19.1M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
UMASS MEDICAL CENTER FOR AIDS RESEARCHP30AI042845 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 1998 to 2012
$13.0M
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and RegenerationU01DK089572 · NIDDK · VANDERBILT UNIVERSITY · PI GREINER, DALE LESLIE, HARLAN, DAVID MARSHALL · 2010 to 2014
$8.4M
Molecular Genetics and Mechanisms of ThrombocytopeniaR01HL077642 · NHLBI · JACKSON LABORATORY · PI SHULTZ, LEONARD D. · 2004 to 2007
$1.7M
NCI NIH HHS CA34196NCI NIH HHS P30 CA034196NHLBI NIH HHS HL077642NHLBI NIH HHS R01 HL077642NIAID NIH HHS AI46629NIAID NIH HHS P01 AI046629NIAID NIH HHS P30 AI042845NIDDK NIH HHS DK089572NIDDK NIH HHS DK32520NIDDK NIH HHS P30 DK032520NIDDK NIH HHS U01 DK089572
6 · The paper itself

Abstract

Basic research in transplantation immunology has relied primarily on rodent models. Experimentation with rodents has laid the foundation for our basic understanding of the biological events that precipitate rejection of non-self or allogeneic tissue transplants and supported the development of novel strategies to specifically suppress allogeneic immune responses. However, translation of these studies to the clinic has met with limited success, emphasizing the need for new models that focus on human immune responses to allogeneic tissues. Humanized mouse models are an exciting alternative that permits investigation of the rejection of human tissues mediated by human immune cells without putting patients at risk. However, the use of humanized mice is complicated by a diversity of protocols and approaches, including the large number of immunodeficient mouse strains available, the choice of tissue to transplant and the specific human immune cell populations that can be engrafted. Here, we present a historical perspective on the study of allograft rejection in humanized mice and discuss the use of these novel model systems in transplant biology.

Indexed as

Disease Models, AnimalOrgan TransplantationAnimalsGraft RejectionHumansMiceMice, Mutant StrainsMice, SCIDTranslational Research, Biomedical

Identifiers

PMID22327213
PMCPMC4012846
OpenAlexW1979856058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.